Publicación:
Características sociodemográficas y perfil de atención médica en pacientes Covid-19 Clínica Juan N. Corpas

Vista sencilla de ítem
dc.contributor.authorGuevara Villalobos, Martha Liliana
dc.contributor.authorPinilla Fonseca, Vanessa Elena
dc.contributor.authorPolanco Rodríguez, Fabián Enrique
dc.contributor.authorSuárez Valencia, Diana Yessenia
dc.coverage.countryColombia
dc.date.accessioned2022-11-28T20:16:22Z
dc.date.available2022-11-28T20:16:22Z
dc.date.issued2021
dc.description.abstractSe analiza una cohorte intrahospitalaria con padecimiento de SARS-COV2, en condiciones de morbilidad moderada a severa, en una institución de III nivel de Complejidad. Se caracterizo el perfil sociodemográfico, de comorbilidad, de patrón clínico COVID-19 al ingreso y evolución, racionalidad y curso de intervenciones diagnósticas, terapéuticas y de los desenlaces vitales.spa
dc.description.abstractAn in-hospital cohort suffering from SARS-COV2 is analyzed, in conditions of moderate to severe morbidity, in a complex level III institution. The sociodemographic, comorbidity, COVID-19 clinical pattern at admission and evolution, rationality and course of diagnostic, therapeutic and vital outcomes interventions were characterized.eng
dc.description.degreelevelEspecializaciónspa
dc.description.degreenameEspecialista en Medicina Familiar Integralspa
dc.description.programEspecialización en Medicina Familiar Integralspa
dc.format.extent69 hojasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.citationGuevara Villalobos, M, Pinilla Fonseca, V, Polanco Rodríguez, F, Suárez Valencia, D., Características sociodemográficas y perfil de atención médica en pacientes Covid-19. Clínica Juan N. Corpas. [Internet]. Bogotá: Fundación Universitaria Juan N. Corpas; 2021. 69 hojas. Recuperado a partir de: https://repositorio.juanncorpas.edu.co/handle/001/139spa
dc.identifier.instnameFundación Universitaria Juan N. Corpasspa
dc.identifier.instnameFundación Universitaria Juan N. Corpasspa
dc.identifier.reponameRepositorio Institucional Fundación Universitaria Juan N. Corpasspa
dc.identifier.reponameRepositorio Institucional Fundación Universitaria Juan N. Corpasspa
dc.identifier.repourlhttps://repositorio.juanncorpas.edu.co/spa
dc.identifier.repourlhttps://repositorio.juanncorpas.edu.co/spa
dc.identifier.urihttps://repositorio.juanncorpas.edu.co/handle/001/139
dc.language.isospaspa
dc.publisherFundación Universitaria Juan N. Corpasspa
dc.publisher.facultyEscuela de Medicinaspa
dc.publisher.placeBogotáspa
dc.relation.indexedRedColspa
dc.relation.references1.Zunyou Wu MP. https://jamanetwork.com. [Online].; 2020 [cited 2021 2 24]. Available from: https://jamanetwork.com/journals/jama/fullarticle/2762130. 2.Suliman Khan RS. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. [Online].; 2020 [cited 2021 2 24]. Available from:https://jcm.asm.org/content/58/5/e00187-20. 3.COBCM Bd. Blog Oficial del Colegio Oficial de Biólogos de la Comunidad de Madrid. [Online].; 2020 [cited 2021 3 21]. Available from: https://cobcm.net/blogcobcm/2020/04/14/sars-cov-2-biologia-estructura/. 4.Gorbalenya AE,B. The species Severe acute respiratory syndrome-related coronavirus. [Online].; 2020 [cited 2021 3 15]. Available from: https://doi.org/10.1038/s41564-020-0695-z. 5.Francisco Javier Díaz-Castrillón AITM. Editorial Medica Colombiana. [Online].; 2020 [cited 2021 2 22]. Available from: https://docs.bvsalud.org/biblioref/2020/05/1096519/covid-19.pdf. 6.Marín JEO. Revista Alerta. [Online].; 2020 [cited 2021 3 12]. Available from: https://doi.org/10.5377/alerta.v3i2.9619. 7.Tolosa A. Genetica Medica News. [Online].; 2020 [cited 2021 3 21]. Available from: https://genotipia.com/genetica_medica_news/coronavirus-estructura-infeccion- celulas/. 8.Bette Korber WMF. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. [Online].; 2020 [cited 20213 21]. Available from: https://www.sciencedirect.com/science/article/pii/S0092867420308205. 9.Vunnam KPP&SR. Springer Nature - Transmission of SARS-CoV-2: an update of current literature. [Online].; 2020 [cited 2021 3 14]. Available from: https://doi.org/10.1007/s10096-020-03961-1. 10.N VD. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. [Online].; 2020 [cited 2021 3 14]. Available from: https://www.nejm.org/doi/full/10.1056/nejmc2004973. 11.Liu RRWyR. Reuters. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.reuters.com/article/salud-coronavirus-anal-idESKCN2AW260. 12.Chen X. British Journal of Ophthalmology. [Online].; 2020. Available from: https://bjo.bmj.com/content/early/2020/08/25/bjophthalmol-2020-316263. 13.Le Chan YYLW. Transfusion Medicine Reviews. [Online].; 2020. Available from: https://www.sciencedirect.com/science/article/pii/S0887796320300146. 14.Melissa M. Arons RN,KM. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. [Online].; 2020 [cited 2021 3 14]. Available from: https://www.nejm.org/doi/full/10.1056/nejmoa2008457. 15.Muge Cevik MT. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. [Online].; 2021 [cited 2021 5 05]. Available from: https://www.sciencedirect.com/science/article/pii/S2666524720301725. 16.Qiu X. Defining the role of asymptomatic SARS-CoV-2 transmission – a living systematic review. [Online].; 2021 [cited 2021 4 14]. Available from: https://www.medrxiv.org/content/10.1101/2020.09.01.20135194v1. 17.Control ECfDPa. European Centre for Disease Prevention and Control. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/surveillance-definitions. 18.Muge Cevik JLM. Clinical Infectious Diseases. [Online].; 2020 [cited 2021 411]. Available from: https://academic.oup.com/cid/advance article/doi/10.1093/cid/ciaa1442/5910315. 19.Sin Fun Sia LMY. Nature. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.nature.com/articles/s41586-020-2342-5. 20.Monteil V. ScienceDirect. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.sciencedirect.com/science/article/pii/S0092867420303998. 21.Varga Z FA. The Lancet. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30937-5/fulltext. 22.Mangalmurti N HC. Immunity. [Online].; 2020 [cited 2021 3 21]. Available from: https://doi.org/10.1016/j.immuni.2020.06.017. 23.Liu PP. Circulation. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047549. 24.Takahashi T. Nature. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.nature.com/articles/s41586-020-2700-3. 25.Lucas C. Nature. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.nature.com/articles/s41586-020-2588-y. 26.National_Cancer_Institute. NCI National Cancer Institute. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.cancer.gov/about-cancer/coronavirus/coronavirus-cancer-patient-i nformation. 27.National_Kidney_Foundation. National Kidney Foundation. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.kidney.org/coronavirus/kidney-disease-covid-19. 28.American_Lung_Association. American_Lung_Association. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.lung.org/lung-health-diseases/lung-disease-lookup/covid-19/chronic-lung-diseases-and-covid. 29.Gajewski M. Forbes. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.forbes.com/sites/mishagajewski/2021/02/09/people-with-dementia-are-twice-as-likely-to-get-covid-19-and-four-times-more-likely-to-die-from-it/. 30.Wang Q. Alzheimer's Association. [Online].; 2021 [cited 2021 4 11]. Available from: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12296. 31.American_Diabetes_Association. American_Diabetes_Association. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes. 32.NDSS. National Down Syndrome Society. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.ndss.org/ndss-covid-19-down-syndrome-resource/. 33.Triana JFF. https://www.elsevier.es. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.elsevier.es/es-revista-revista-colombiana-cardiologia-203-articulo- covid-19-enfermedad-cardiovascular-S0120563320300760. 34.NIH. National Institute Health. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/hiv/. 35.NIH. National Institute of Allergy and Infectious Diseasses. [Online].; 2020 [cited 2021 4 11]. Available from: https://www.niaid.nih.gov/diseases-conditions/types-pidds. 36.CDC. Centers for Disease Control and Prevention. [Online].; 2021 [cited 20214 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/liver-disease.html. 37.Shetye B. Obesityaction. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.obesityaction.org/community/covid-19-and-obesity-what-does-it-mean-for-you/. 38.CDC. Centers for Diseasse Control and Prevention. [Online].; 2021 [cited 20214 11]. Available from: https://www.cdc.gov/obesity/data/obesity-and-covid-19.html. 39.Lokken EM. American Journal of Obstetrics Gynecology. [Online].; 2021 [cited 2021 4 11]. Available from: https://www.ajog.org/article/S0002-9378(21)00098-3/fulltext. 40. Jimenez-Ruiz CA. Archivos de Bronconeumología. [Online].; 2020 [cited 20214 11]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381922/. 41.Ortiz M. Acta Neurologica Colombiana. [Online].; 2020 [cited 2021 4 11]. Available from: https://doi.org/10.22379/24224022280. 42.OMS. Organización Mundial de la Salud. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.who.int/es/news-room/feature-stories/detail/how-do-vaccines-work. 43.FH. https://www.huesped.org.ar. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.huesped.org.ar/informacion/vacunas/que-son-y-como-funcionan/. 44.Salud OMdl. https://www.who.int/es. [Online].; 2021 [cited 2021 3 21]. Available from:https://www.who.int/es/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained. 45.Bolan B. Banner Health. [Online].; 2020 [cited 2021 3 21]. Available from: https://www.bannerhealth.com/es/healthcareblog/teach-me/what-is-herd-immunity. 46.INS_Colombia. Ministerio de Salud y Protección Social. [Online].; 2020 [cited 2021 3 21. Available from: https://www.minsalud.gov.co/Paginas/Como-se-desarrolla-una-vacuna.aspx. 47.College_Philadelphia. The College of Physicians of Philadelphia. [Online].; 2018 [cited 2021 3 21]. Available from: https://www.historyofvaccines.org/index.php/es/contenido/articulos/desarrollo-pruebas-y-reglamentos-para-las-vacunas. 48.Financial_Times. Financial Times. [Online].; 2021 [cited 2021 3 21]. Available from: https://www.ft.com/content/ac5e5ef8-bccb-482b-9f8d-0dab5cac6f9a. 49.Plotkin SA,OWA,OPA. https://www.historyofvaccines.org. [Online].; 2018 [cited 2021 03 21]. Available from: https://www.historyofvaccines.org/es/contenido/articulos/diferentes-tipos-de-va cunas. 50.Hoffmann. BSK&C. The Lancet - Infectious Disease. [Online].; 2020 [cited 2021 5 3. Available from: https://doi.org/10.1016/S1473-3099(20)30581-8. 51.Worldmeter. www.worldometers. [Online].; 2021 [cited 2021 5 3. Available from: https://www.worldometers.info/. 52.SaludBogota. SaluData. [Online].; 2020 [cited 2021 1 31]. Available from: https://saludata.saludcapital.gov.co/osb/index.php/datos-de-salud/enfermedad es-trasmisibles/covid19/. 53.Carthaus A. Coronavirus: El factor R y los cuatro parámetros de contagio. [Online].; 2020 [cited 2021 3 31]. Available from: https://p.dw.com/p/3bH4u. 54.Diaz JA. RTColombia. [Online].; 2020 [cited 2021 3 31]. Available from: http://www.rtcolombia.com. 55.Statista. Statista.com. [Online].; 2021 [cited 2021 3 30]. Available from: https://es.statista.com/. 56.MinSalud. Ministerio de Salud Colombia. [Online].; 2021 [cited 2021 3 31]. Available from: https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx.spa
dc.rightsTodos los derechos reservados conforme a la ley. Se permite la reproducción citando fuente. El pensamiento que se expresa en esta obra, es exclusiva responsabilidad de los autores y no compromete la ideología de la Fundación Universitaria Juan N. Corpas.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.licenseAtribución 4.0 Internacional (CC BY 4.0)spa
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/spa
dc.sourcehttps://repositorio.juanncorpas.edu.cospa
dc.subject.meshSARS-CoV-2 - Atención a la Salud
dc.subject.meshCoronavirus 2, SARS - Atención médica
dc.subject.meshPandemia de COVID-19 - Complicaciones
dc.subject.proposalCOVID 19spa
dc.subject.proposalSeveridadspa
dc.subject.proposalComorbilidadspa
dc.subject.proposalPredictores gravedadspa
dc.subject.proposalSeverityeng
dc.subject.proposalComorbidityeng
dc.subject.proposalSeverity predictorseng
dc.titleCaracterísticas sociodemográficas y perfil de atención médica en pacientes Covid-19 Clínica Juan N. Corpasspa
dc.typeTrabajo de grado - Especializaciónspa
dc.type.coarhttp://purl.org/coar/resource_type/c_46ecspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/otherspa
dc.type.redcolhttps://purl.org/redcol/resource_type/INFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dcterms.audienceComunidad Académica Universitariaspa
dspace.entity.typePublication

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
MarthaLilianaGuevaraVillalobos_2021.pdf
Tamaño:
3.66 MB
Formato:
Adobe Portable Document Format
Descripción:
Características sociodemográficas y perfil de atención médica en pacientes Covid-19 Clínica Juan N. Corpas
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
14.45 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

BD. Especialización en Medicina Familiar Integral